Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis
Lab / animal
OA: closed
CC0
⤵ 132 in-corpus citations
AI-generated summary
Endometriotic stromal cells exhibit increased SF-1 expression due to hypomethylation of its 5' CpG island, unlike eutopic endometrial cells where methylation silences SF-1.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
CONTEXT: Endometriosis is an estrogen-dependent disease. Steroidogenic factor-1 (SF-1), a transcriptional factor essential for activation of multiple steroidogenic genes for estrogen biosynthesis, is undetectable in normal endometrial stromal cells and aberrantly expressed in endometriotic stromal cells.
OBJECTIVE: The objective of the study was to unravel the mechanism for differential SF-1 expression in endometrial and endometriotic stromal cells.
DESIGN: We identified a CpG island flanking the SF-1 promoter and exon I region and determined its methylation patterns in endometrial and endometriotic cells.
SETTING: The study was conducted at Northwestern University.
PATIENTS OR OTHER PARTICIPANTS: Eutopic endometrium from disease-free subjects (n = 8) and the walls of cystic endometriosis lesions of the ovaries (n = 8) were investigated.
INTERVENTION(S): Stromal cells were isolated from these two types of tissues.
MAIN OUTCOME MEASURE(S): Measures are mentioned in Results.
RESULTS: SF-1 mRNA and protein levels in endometriotic stromal cells were significantly higher than those in endometrial stromal cells (P < 0.001). Bisulfite sequencing showed strikingly increased methylation in endometrial cells, compared with endometriotic cells (P < 0.001). Demethylation by 5-aza-2'-deoxycytidine increased SF-1 mRNA levels by up to 55.48-fold in endometrial cell (P < 0.05). Luciferase assays showed that the -85/+239 region bearing the CpG island regulated its activity (P < 0.01). Natural or in vitro methylation of this region strikingly reduced SF-1 promoter activity in both cell types (P < 0.01). Chromatin immunoprecipitation assay showed that methyl-CpG-binding domain protein 2 binds to the SF-1 promoter in endometrial but not endometriotic cells.
CONCLUSIONS: This is the first demonstration of methylation-dependent regulation of SF-1 in any mammalian tissue. These findings point to a new mechanism for targeting local estrogen biosynthesis in endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (51)
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium via openalex
- Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue via openalex
- Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element via openalex
- W1986193321 via openalex
- W1990307219 via openalex
- W1994663658 via openalex
- W1994734085 via openalex
- W1995470989 via openalex
- W2010611789 via openalex
- W2031993397 via openalex
- W2041674913 via openalex
- W2046241907 via openalex
- W2052697893 via openalex
- W2055723072 via openalex
- W2061076014 via openalex
- W2069949978 via openalex
- W2076619054 via openalex
- W2082685929 via openalex
- W2087979994 via openalex
- W2091658754 via openalex
- W2092174240 via openalex
- W2100859941 via openalex
- W2103365149 via openalex
- W2108377754 via openalex
- W2109525253 via openalex
- W2114313427 via openalex
- W2135877336 via openalex
- W2168615744 via openalex
- W4211081176 via openalex
- W4240827234 via openalex
- W4241805443 via openalex
- W6629311803 via openalex
- W6646498800 via openalex
- W6648095168 via openalex
- W6664125244 via openalex
- W151363419 via openalex
- W6814680148 via openalex
- W822073298 via openalex
- W1489536527 via openalex
- W1536476995 via openalex
- W1552528612 via openalex
- W1577584933 via openalex
- W1984004239 via openalex
- W1985336724 via openalex
- W1985473949 via openalex
Cited by (50)
- Precision medicine approaches for targeted therapy in endometriosis: A promising future 2026
- Methylation Risk Score Modelling in Endometriosis: Evidence for Non-Genetic DNA Methylation Effects in a Case-Control Study 2025
- Leveraging epigenetic aberrations in the pathogenesis of endometriosis: from DNA methylation to non-coding RNAs 2025
- Endometriosis: A new perspective on epigenetics and oxidative stress 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- Epigenetics of endometriosis 2025
- Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway 2024
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- The Effect of EGFR DNA Methylation on the Incident of Endometriosis 2024
- Epigenetic Landscapes of Endometriosis: From Pathogenesis to Precision Medicine 2024
- DNA methylation profiles of ovarian cysts resemble ovarian tissues, but not endometrial tissues 2023
- Global endometrial DNA methylation analysis reveals insights into mQTL regulation and associated endometriosis disease risk and endometrial function 2023
- Genetics and genomics of endometriosis☆ 2023
- Epigenetics, endometriosis and sex steroid receptors: An update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis 2023
- The Association between Deoxyribonucleic Acid Hypermethylation in Intron VII and Human Leukocyte Antigen-C∗07 Expression in Patients with Endometriosis 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics 2023
- Translational aspects of the endometriosis epigenome 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- Integrated analysis of genome-wide gene expression and DNA methylation profiles reveals candidate genes in ovary endometriosis 2023
- Is endometriosis due to evolutionary maladaptation? 2023
- Promoter Methylation Levels of Progesterone Receptor-B (PR-B) and Expression of mRNA DNA Methyltransferase-1 (DNMT-1) In Menstrual Blood Patients with Endometriosis 2023
- Global Endometrial DNA Multi-omics Analysis Reveals Insights into mQTL Regulation and Associated Endometriosis Disease Risk 2022
- Tumor Necrosis Factor Affects Steroidogenic Factor-1 Expression in Ovarian Granular Cells Via Inducing Gene Methylation 2022
- Epigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility 2022
- Progesterone Actions and Resistance in Gynecological Disorders 2022
- Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity 2022
- Endometriosis-associated infertility: From pathophysiology to tailored treatment 2022
- Molecular and Cellular Changes in the Pathogenesis of Endometriosis 2021
- DNMT1 and DNMT3B gene variants and their association with endometriosis in South Indian women 2021
- WITHDRAWN: Endometriosis related sex steroid hormones, hypothalamic pituitary gonadal axis hormones and related animal modeling: A comprehensive review of published articles and endometriosis induction methods from 2010 to 2021 with scoring based approach 2021
- Insights Gained from Genomic Studies on the Role of Sex Steroids in the Aetiology of Endometriosis 2021
- Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells 2020
- Aberrant epigenetics and reproductive disorders 2020
- Analysis of mRNA expression and DNA methylation level of RAC1 gene encoding focal adhesion molecule in endometrial and peritoneal endometriosis 2020
- Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis 2020
- Epigenetics of Estrogen and Progesterone Receptors in Endometriosis 2020
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis 2020
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis 2020
- Effect of epigallocatechin-3-gallate on the status of DNA methylation of E-cadherin promoter region on endometriosis mouse 2020
- Endometriosis, endocrine disrupters, and epigenetics: an investigation into the complex interplay in women with polybrominated biphenyl exposure and endometriosis 2020
- Epithelial Mutations in Endometriosis: Link to Ovarian Cancer 2019
- Endometriosis 2019
- Endometriosis 2019
- Progesterone Resistance and Adult Stem Cells’ Genomic and Epigenetic Changes in the Puzzle of Endometriosis 2019
- Loss of HDAC3 results in nonreceptive endometrium and female infertility 2019
- Hypoxia: The force of endometriosis 2019
- Endometriosis and nuclear receptors 2019
- The Origin and Pathogenesis of Endometriosis 2019
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:04:24.806248+00:00
License: CC0
· commercial use OK